DexCom Revenue 2010-2025 | DXCM

DexCom annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • DexCom revenue for the quarter ending March 31, 2025 was $1.036B, a 12.49% increase year-over-year.
  • DexCom revenue for the twelve months ending March 31, 2025 was $4.148B, a 9.11% increase year-over-year.
  • DexCom annual revenue for 2024 was $4.033B, a 11.34% increase from 2023.
  • DexCom annual revenue for 2023 was $3.622B, a 24.49% increase from 2022.
  • DexCom annual revenue for 2022 was $2.91B, a 18.84% increase from 2021.
DexCom Annual Revenue
(Millions of US $)
2024 $4,033
2023 $3,622
2022 $2,910
2021 $2,449
2020 $1,927
2019 $1,476
2018 $1,032
2017 $719
2016 $573
2015 $402
2014 $259
2013 $160
2012 $100
2011 $76
2010 $49
2009 $30
DexCom Quarterly Revenue
(Millions of US $)
2025-03-31 $1,036
2024-12-31 $1,114
2024-09-30 $994
2024-06-30 $1,004
2024-03-31 $921
2023-12-31 $1,035
2023-09-30 $975
2023-06-30 $871
2023-03-31 $742
2022-12-31 $815
2022-09-30 $770
2022-06-30 $696
2022-03-31 $629
2021-12-31 $698
2021-09-30 $650
2021-06-30 $595
2021-03-31 $505
2020-12-31 $569
2020-09-30 $501
2020-06-30 $452
2020-03-31 $405
2019-12-31 $463
2019-09-30 $396
2019-06-30 $336
2019-03-31 $281
2018-12-31 $338
2018-09-30 $267
2018-06-30 $243
2018-03-31 $184
2017-12-31 $221
2017-09-30 $185
2017-06-30 $171
2017-03-31 $142
2016-12-31 $171
2016-09-30 $149
2016-06-30 $137
2016-03-31 $116
2015-12-31 $131
2015-09-30 $105
2015-06-30 $93
2015-03-31 $73
2014-12-31 $84
2014-09-30 $69
2014-06-30 $59
2014-03-31 $47
2013-12-31 $52
2013-09-30 $43
2013-06-30 $36
2013-03-31 $30
2012-12-31 $33
2012-09-30 $23
2012-06-30 $23
2012-03-31 $20
2011-12-31 $22
2011-09-30 $18
2011-06-30 $21
2011-03-31 $14
2010-12-31 $16
2010-09-30 $12
2010-06-30 $12
2010-03-31 $10
2009-12-31 $10
2009-09-30 $7
2009-06-30 $7
2009-03-31 $5
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $32.486B $4.033B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $183.869B 80.53
Thermo Fisher Scientific (TMO) United States $156.785B 18.97
Edwards Lifesciences (EW) United States $44.517B 29.19
Alcon (ALC) Switzerland $43.958B 29.71
IDEXX Laboratories (IDXX) United States $42.376B 48.70
IQVIA Holdings (IQV) United States $27.529B 15.42
Mettler-Toledo (MTD) United States $24.694B 29.37
STERIS (STE) Ireland $23.846B 26.26
Waters (WAT) United States $20.803B 29.35
SONOVA HOLDING (SONVY) Switzerland $18.964B 0.00
Hologic (HOLX) United States $14.534B 15.79
Sysmex ADR (SSMXY) Japan $10.991B 31.18
Penumbra (PEN) United States $9.813B 77.02
Masimo (MASI) United States $8.965B 33.07
Globus Medical (GMED) United States $8.150B 19.42
Glaukos (GKOS) United States $5.577B 0.00
Teleflex (TFX) United States $5.395B 8.91
TransMedics (TMDX) United States $4.838B 105.18
Integer Holdings (ITGR) United States $4.143B 21.71
PROCEPT BioRobotics (PRCT) United States $3.384B 0.00
LivaNova (LIVN) United Kingdom $2.543B 15.14
Nihon Kohden (NHNKY) Japan $2.185B 25.06
Veracyte (VCYT) United States $2.090B 29.33
Elekta AB (EKTAY) Sweden $1.972B 17.72
Alphatec Holdings (ATEC) United States $1.662B 0.00
Tandem Diabetes Care (TNDM) United States $1.393B 0.00
Artivion (AORT) United States $1.227B 114.96
Pulse Biosciences (PLSE) United States $1.088B 0.00
OPKO Health (OPK) United States $1.063B 0.00
Integra LifeSciences Holdings (IART) United States $0.986B 5.24
Beta Bionics (BBNX) United States $0.845B 0.00
SiBone (SIBN) United States $0.778B 0.00
IRadimed (IRMD) United States $0.757B 38.43
RxSight (RXST) United States $0.580B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.572B 8.90
Mesa Laboratories (MLAB) United States $0.545B 12.77
Delcath Systems (DCTH) United States $0.545B 0.00
OrthoPediatrics (KIDS) United States $0.528B 0.00
AxoGen (AXGN) United States $0.457B 0.00
AngioDynamics (ANGO) United States $0.442B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.437B 0.00
Treace Medical Concepts (TMCI) United States $0.369B 0.00
NeuroPace (NPCE) United States $0.368B 0.00
Pacific Biosciences Of California (PACB) United States $0.354B 0.00
Semler Scientific (SMLR) United States $0.343B 9.12
ClearPoint Neuro (CLPT) United States $0.338B 0.00
908 Devices (MASS) United States $0.258B 0.00
Neuronetics (STIM) United States $0.251B 0.00
Tactile Systems Technology (TCMD) United States $0.231B 14.01
Sight Sciences (SGHT) United States $0.218B 0.00
Alpha Tau Medical (DRTS) Israel $0.216B 0.00
Biosig Technologies (BSGM) United States $0.189B 0.00
Spectral Diagnostics (EDTXF) Canada $0.184B 0.00
Anteris Technologies Global (AVR) Australia $0.176B 0.00
Inogen (INGN) United States $0.173B 0.00
Rapid Micro Biosystems (RPID) United States $0.158B 0.00
CVRx (CVRX) United States $0.154B 0.00
LENSAR (LNSR) United States $0.147B 0.00
Lucid Diagnostics (LUCD) United States $0.142B 0.00
Accuray (ARAY) United States $0.129B 0.00
Atossa Genetics (ATOS) United States $0.111B 0.00
Monogram Orthopaedics (MGRM) United States $0.094B 0.00
Microbot Medical (MBOT) United States $0.090B 0.00
Sensus Healthcare (SRTS) United States $0.082B 49.70
EnVVeno Medical (NVNO) United States $0.077B 0.00
InspireMD (NSPR) United States $0.077B 0.00
EDAP TMS S.A (EDAP) France $0.066B 0.00
Hyperfine (HYPR) United States $0.058B 0.00
Spectral AI (MDAI) United States $0.054B 0.00
Vicarious Surgical (RBOT) United States $0.052B 0.00
Precision Optics (POCI) United States $0.037B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Envoy Medical (COCH) United States $0.031B 0.00
Baird Medical Investment Holdings (BDMD) $0.028B 0.00
Adagio Medical Holdings (ADGM) United States $0.018B 0.00
NexGel (NXGL) United States $0.017B 0.00
WORK Medical Technology Group (WOK) China $0.012B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.010B 0.00
Ekso Bionics Holdings (EKSO) United States $0.009B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.008B 0.00
ReShape Lifesciences (RSLS) United States $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.54